Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$80,944,003
+$16,733,485 QoQ
Shares Held
1,688,444
-3.4% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#39
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. NVO ranks #10 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,944,003 | 1,688,444 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $64,210,518 | 1,747,225 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $88,336,633 | 1,736,176 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $80,433,364 | 1,449,511 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $111,086,308 | 1,609,480 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $100,152,962 | 1,442,295 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $113,435,948 | 1,318,716 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $143,418,384 | 1,204,488 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $156,770,483 | 1,098,294 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $141,309,336 | 1,100,540 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $109,888,519 | 1,062,238 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $97,408,196 | 1,071,126 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $80,155,692 | 495,308 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $71,259,389 | 447,778 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $63,576,775 | 469,756 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $47,116,620 | 472,916 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $65,068,433 | 583,940 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $91,188,262 | 821,146 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $93,109,520 | 831,335 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $81,855,244 | 852,570 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $80,542,172 | 961,468 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $62,674,776 | 929,617 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $64,144,721 | 918,321 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $62,747,500 | 903,752 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $46,125,551 | 704,422 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $82,502,052 | 1,370,466 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||